Genmab — Oktober 2023

[ProinvestorNEWS]

Biotech Stocks Facing FDA Decision In November 2023 https://www.proinvestor.com/investornyt/1070743/biotech-stocks-facing-fda-decision-in-november-2023

[E_L]

AbbVie Inc. (NYSE:ABBV) Q3 2023 Earnings Call Transcript https://finance.yahoo.com/news/abbvie-inc-nyse-abbv-q3-170643822.html - Moving to oncology, where in the quarter, we received approval in Europe and Japan for epcoritamab as a monotherapy treatment for patients with relapsed or refractory DLBCL, were received two or more systemic therapies. These approvals represent important regulatory milestones for EPCO, and we look forward to bringing this new subcutaneous treatment option to patients

[E_L]

in these international markets. We also continue to make good progress with the development programs in earlier lines of DLBCL and follicular lymphoma and we look forward to providing updates on these programs as the data mature.

[E_L]

The U.S. launch of at EPKINLY in third line plus DLBCL is also tracking well with commercialization also now underway in Europe and Japan, following the recent respective approvals.

[E_L]

We are still moving into earlier lines in Phase 3s with EPKINLY in heme, which is another dual engager.

[Helge_LarsenPI-redaktør]

Godmorgen

[Stroka]

God morgen

[bibob]

God morgen.

[ungeee]

Genmab får barberet kursmålet hos Carnegie
30.10.2023 07.42 • MarketWire •
Kopier link til udklipsholderen
Genmab har fået sænket kursmålet til 2725 kr. fra 3430 kr. hos Carnegie.
Det viser data fra Bloomberg News.

Anbefalingen "køb" gentages.

Genmab faldt fredag 1,0 pct. til 2007 kr.

.\˙ MarketWire

Morten Frederik Heltoft

[E_L]

we will probably get a few more of these, they always come after a fall...

[Klarussen]

Does seem to affect the stock much though this time, I suppose is all counted in

[Raun]

Er vi ikke ved at være der, sådan rent kursmæssigt.... At vi kan sige, - hvis der er nogen der er interesseret i at købe Genmab. Så er det nu?

[Klarussen]

Jo da

[Vitus]

Vi kan vist synes hvad vi vil….

[Klarussen]

Ja da, det er jo et (forholdsvist) frit land

[E_L]

#ESMO23 Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC https://oncologypro.esmo.org/meeting-resources/esmo-congress/esmo23-expert-video-reports/esmo23-expert-video-report-on-amivantamab-in-combination-therapy-for-1l-treatment-in-egfrm-advanced-nsclc

[JKY_VH]

Raun 11:36, hvis der kommer en person forbi med en meget stor papkasse vil jeg da overveje at tjekke indholdet af papkassen;-)

[Vitus]

Trist aktien falder under utrolig lav omsætning…….så er den billig ……

[Gasolin82]

Det som overrasker mig mest er, at aktien ikke rebounder efter så voldsomt et fald. Tværtimod har den stabiliseret sig omkring kurs 2000 i over en uge nu. Regnede med en kraftig reaktion opad efter de forgangne ugers kæmpe sell-off.

[Raun]

JKY_VH.... ...... Nu mener jeg jo bare at der er jo nogle herindem som føler sig overbevist om at Genmab vil blive solgt på et tidspunkt..... Tænker så bare at hvis ikke Genmab bliver soldt til nuværende kursniveau. Så kan det scenarie vel godt manes til jorden - en gang for alle?